190,191 Pharmacological EZH2 inhibition induces a change in the production of pro-inflammatory cytokines which promotes anti-tumor activity and significantly increases the ratio between CD8+ T and Tregs in the tumor microenvironment.190. This evidence concerns the gene CD8A and neoplasm.